All In Biotech

Free tool

FAERS Monitor: Oraverse

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022159 or its brand name (Oraverse, Phentolamine Mesylate). Reports on generic versions are filed under their own applications.

Reports

112

Serious

89

79% of reports

Hospitalization

45

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood urea increased14
  • blood glucose increased13
  • neutrophil count increased13
  • anaemia12
  • diarrhoea12
  • lymphocyte count decreased12
  • hypertension11
  • dizziness10
  • haemoglobin decreased10
  • abdominal distension9
  • hypoaesthesia9
  • pyrexia9
  • dyspnoea8
  • platelet count decreased8
  • abdominal sepsis7

Reports by year received

View as table
YearReports
20042
20052
20076
20081
20094
20102
201115
20126
20131
20143
20153
20165
201720
20189
20195
20206
20216
20224
20233
20254
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,047 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abdominal sepsisSignal71505.6732.69,003
neutrophil count increasedSignal13238.7143.22,842
blood urea increasedSignal14157.296.32,019
lymphocyte count decreasedSignal12127.674.71,383
haemoglobin decreasedSignal1018.310.1147
abdominal distensionSignal916.28.7114
platelet count decreasedSignal814.17.285
blood glucose increasedSignal1313.07.8133
anaemiaSignal1211.86.9109
hypoaesthesiaSignal911.36.075
hypertensionSignal119.85.679
pyrexiaSignal94.92.624
dizzinessSignal103.82.118
diarrhoeaSignal123.52.020
dyspnoeaSignal82.71.47

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.